Privia Health Group, Inc. IPO Advisory
Share this IPO Profile:
Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
Privia Health Group, Inc. | PRVA - NASDAQ |
$21.00-$23.00 |
$23.00 |
$30.00 | 19.5 million | 4/29/2021 |
Goldman Sachs, JP Morgan, Credit Suisse, Piper Sandler, William Blair, Canaccord Genuity, Truist Securities |
Co-Manager(s): R. Seelaus & Co., Siebert Williams Shank |
Health Care |
Filing(s): Filed 2021-04-07 Terms Added 2021-04-22 Terms Changed 2021-04-01
|
For IPO Boutique's "scale of 1 to 5" BUY rating on Privia Health Group, Inc., and our comprehensive analysis, click "Buy Market Research".
Privia Health Group, Inc. Quote & Chart - Click for current quote -
PRVA
About Privia Health Group, Inc. (adapted from Privia Health Group, Inc. prospectus):
Privia Health is a technology-driven, national physician-enablement company that collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "PRVA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2024 IPO Boutique. All Rights Reserved